TTUHSC Research Receives Prestigious Status as Carnegie Classification® for Special Focus Four-Year Research Institution
The Carnegie Classification® of Institutions of Higher Education has designated Texas Tech University Health Sciences Center (TTUHSC) as a Special Focus Four-Year Research Institution.
CPRIT awarded a four-year, $1.34 million grant to C. Patrick Reynolds, M.D., Ph.D., director for the School of Medicine Cancer Center at the Texas Tech University Health Sciences Center.
Alongside Texas Tech University and 2THEDGE, a leading technology consulting and investing firm, TTUHSC unveiled the groundwork of a future public-private collaboration supporting the advancement of Unmanned Aerial Systems (UAS) research at a summit event on the TTUHSC campus Wednesday, April 6.
Nadia German, Ph.D., and collaborator Constantinos Mikelis, Ph.D., have received a U.S. patent for a chemical that targets the brain’s dopamine transporter.
The National Cancer Institute awarded a five-year, $1.9 million grant to C. Patrick Reynolds, M.D., Ph.D., director for the School of Medicine Cancer Center at TTUHSC.
To gain insight into the potential relationship between ROS accumulation in the dentate gyrus and the onset of Alzheimer’s disease, the National Institutes of Health recently awarded a five-year, $1.87 million grant to TTUHSC's J. Josh Lawrence, Ph.D.
The global preeminence of TTUHSC is highlighted by a widely publicized citation database created at Stanford University. The comprehensive database shows that TTUHSC is the academic home to several of the world’s top-ranked biomedical and pharmaceutical researchers.
In its most recent funding cycle, the Cancer Prevention & Research Institute of Texas (CPRIT) awarded a $2,499,999 grant extension to Rakhshanda Rahman, M.D., professor of breast surgical oncology at the Texas Tech University Health Sciences Center School of Medicine and the founding executive director of the school’s multi-campus Breast Center of Excellence (BCE).
To continue her research, the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes for Health (NIH) recently awarded Michaela Jansen, Pharm.D., Ph.D., a four-year, $1.53 million grant.
To better understand the role of extracellular vesicles in the spread and progression of LAM, the NIH recently awarded a four-year, $2.8 million grant to Magdalena Karbowniczek, M.D., Ph.D., a professor of immunotherapeutics and biotechnology at the TTUHSC Jerry H. Hodge School of Pharmacy.
The National Institutes of Health (NIH) recently awarded a five-year, $2.76 million grant to Volker E. Neugebauer, M.D., Ph.D. and Igor Ponomarev, Ph.D.
A team of researchers led by Hongjun (Henry) Liang, Ph.D., from the Texas Tech University Health Sciences Center (TTUHSC) Department of Cell Physiology and Molecular Biophysics, recently investigated whether or not a series of novel nanoparticles can kill some of the pathogens that lead to human infection without affecting healthy cells.
The Texas Tech Office of Research Commercialization (ORC) filed an initial U.S. patent application in 2016, and a patent was awarded to Prien and Penrose on Nov. 8, 2021.
Hironmoy Das, Ph.D., a professor of pharmaceutical sciences at the Texas Tech University Health Sciences Center (TTUHSC) Jerry H. Hodge School of Pharmacy, developed a technology derived from corneal epithelial stem cells to improve outcomes for DED patients.
Study of CVD Risk Factors on Cognitive Dysfunction in Elderly Rural West Texans Presented in Journal of Alzheimer’s Disease Reports
A team of researchers led by P. Hemachandra Reddy, Ph.D., professor of internal medicine, neurology and neuroscience at the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine and Hafiz Khan, Ph.D., professor for the Julia Jones Matthews Department of Public Health at the TTUHSC Graduate School of Biomedical Sciences, completed a study to better understand the risk factors for cardiovascular disease (CVD), dementia and Alzheimer’s disease in a rural population.
Ashish Sarangi, M.D., recently conducted research into the mental health consequences of COVID-19 geriatric care in a nursing home setting. His research, “A Descriptive Study Evaluating the Impact of COVID-19 on Delivery of Care and Mental Health of Geriatric Nursing Home Staff,” was published in the April issue of the American Journal of Geriatric Psychiatry.
In a focused review to Physiological Reports, Vardan Karamyan, Ph.D., addresses three peptides that could be causing severe COVID-19 complications
During a virtual presentation of the 2021 TTUHSC State of the University & Faculty Award Convocation, faculty members and teams were recognized for excellence in teaching, research, teamwork and more.
Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder in reproductive- aged women. It affects at least 10% of women, increasing their risk of obesity, diabetes, heart disease, cancer and infertility. To help improve the health of these women, a research team led by Jennifer Phy, D.O., an associate professor at the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine, developed a new dietary approach to managing the syndrome.
At the Texas Tech University Health Sciences Center (TTUHSC), a research team led by Duke Appiah, Ph.D., an assistant professor and director of the university’s master of public health program, recently completed a study to better understand how LS7 may influence ocular health.
- #Breast Center of Excellence
- #Campus Life
- #F. Marie Hall Institute for Rural and Community Health
- #F. Marie Hall SimLife Center
- #Feature Stories
- #Garrison Institute on Aging
- #Graduate School of Biomedical Sciences
- #Laura W. Bush Institute for Women's Health
- #Mental Health Initiative
- #News Releases
- #Paul L. Foster School of Medicine
- #Permian Basin
- #Public Art
- #School of Health Professions
- #School of Medicine
- #School of Nursing
- #School of Pharmacy
- #Texas Tech Physicians
- #The Free Clinic
- #TTUHSC in the News
- #Women's Health